<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The recently <z:e sem="disease" ids="C0877373" disease_type="Neoplastic Process" abbrv="">advanced cancer</z:e> stem cell model postulates that progression and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> are mainly driven by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells with stem cell properties </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0346627" disease_type="Neoplastic Process" abbrv="">Intestinal cancer</z:e> stem cells are difficult to study due to the lack of reliable markers, but expression of the Wnt target gene Lgr5 is promising to define at least stem cell like cells in intestinal and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to find a possible link of stem cell like <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells to the metastatic process of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>To this end, we evaluated immunohistochemical Lgr5 expression in 31 distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> and in <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> compartments with relevance for metastasizing, comprising 89 colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Lgr5 expression was seen in 51.6% of distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>12.9%, 14.8% and 26.7% of <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> with histologically confirmed <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> buds, angioinvasion and perineural infiltrates, respectively, showed evidence of Lgr5 expression in these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> compartments </plain></SENT>
<SENT sid="6" pm="."><plain>However, distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e>, which were derived from <z:mp ids='MP_0002038'>carcinomas</z:mp> with such Lgr5 positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> compartments, showed 6- to 11.5-fold higher median value of Lgr5 expression compared to those <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> derived from <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> without Lgr5 expressing cells in these compartments </plain></SENT>
<SENT sid="7" pm="."><plain>These differences between the <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> were statistically significant, if being related to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> buds (<z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>; p = 0.047) and to vascular infiltrates (stage IV <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>; p = 0.007) </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, our results point to rare evidence of Lgr5 positive stem cell like cells in the metastatic cascade of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, but these few cells might be biologically powerful in the metastatic process of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> subsets </plain></SENT>
<SENT sid="9" pm="."><plain>Clonal analysis is necessary to proof this hypothesis </plain></SENT>
</text></document>